ACADIA Pharmaceuticals, based in San Diego, CA, is a pioneering neuroscience company that has been at the forefront of healthcare for over 25 years. They are dedicated to developing innovative solutions to address unmet medical needs and elevate the lives of those in need. With FDA-approved treatments for Parkinson's Disease Psychosis and Rett syndrome, as well as ongoing clinical-stage developments in areas such as schizophrenia, Alzheimer's disease psychosis, and rare diseases, ACADIA is committed to fighting diseases and ensuring a brighter future for all.
Driven by their mission to elevate life, ACADIA Pharmaceuticals embraces diversity, collaboration, and resilience in their pursuit of developing therapies that make a difference. They provide not only essential therapies but also support, education, and connection to patients fighting diseases. With a focus on advancing breakthroughs in neuroscience, ACADIA is dedicated to improving the lives of individuals and families affected by neurological disorders.
Generated from the website